{
    "nctId": "NCT04268693",
    "briefTitle": "Bisphenol and Phthalate Exposures in Triple Negative Breast Cancer",
    "officialTitle": "Bisphenol and Phthalate Exposures in Women With Triple Negative Breast Cancer Receiving Doxorubicin Chemotherapy - a Pilot Study",
    "overallStatus": "WITHDRAWN",
    "conditions": "Triple Negative Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "urinary bisphenol and phthalate metabolite levels",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* diagnosis of stage I - III triple negative breast cancer\n* scheduled to receive a neoadjuvant chemotherapy regimen including doxorubicin\n* receiving treatment at the George Washington University Cancer Center\n\nExclusion Criteria:\n\n* diagnosis of other types of breast cancer\n* not scheduled to receive doxorubicin as part of the neoadjuvant chemotherapy regimen\n* not planning to receive neoadjuvant chemotherapy at the George Washington University Cancer Center",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}